Performance of cytology and human papillomavirus testing in relation to the menstrual cycle

British Journal of Cancer

Volumn 94, Issue 11, 2006, Pages 1690-1696

  Sherman, M E ^a   Carreon, J D ^a   Schiffman, M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervix; Cytology; Epidemiology; Human papillomavirus; Menstrual cycle; Screening

Indexed keywords

VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; DNA DETERMINATION; FALSE NEGATIVE RESULT; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STANDARDIZATION; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; WART VIRUS;

CARCINOMA IN SITU; CERVIX UTERI; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MENSTRUAL CYCLE; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33745233276     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603151     Document Type: Article

References (39)

1. Agoff SN, Dean T, Nixon BK (2002) The efficacy of reprocessing unsatisfactory cervicovaginal ThinPrep Specimens with and without glacial acetic acid. Am J Clin Pathol 118: 727-732
2. Arbeit JM, Howley PM, Hanahan D (1996) Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci 93: 2930-2935
3. Baldwin P, Laskey R, Coleman N (2003) Translational approaches to improving cervical screening. Nat Rev 3: 217-226
4. Bernstein SJ, Sanchez-Ramos L, Ndubisi B (2001) Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanlysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 185: 308-317
5. Boon ME, Ouwerkerk-Noordam E, van Leeuwen AWMF, Van Haaften-Day C (2003) Clinical and diagnostic significance of blood in cervical smears. Diagn Cytopathol 28: 181-185
6. Brake T, Lambert PF (2005) Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci 102: 2490-2495
7. Castle PE, Wheeler CM, Solomon D, Schiffman M, Peyton CL, for the ALTS Group (2004) Interlaboratory reliability of Hybrid Capture 2. Am J Clin Pathol 122: 238-245
8. Elson DA, Riley RR, Lacey A, Thordarson G, Talamantes FJ, Arbeit JM (2000) Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res 60: 1267-1275
9. Fairley CK, Robinson PM, Chen S, Tabrizi SN, Garland SM (1994) The detection of HPV DNA, the size of tampon specimens and the menstrual cycle. Genitourin Med 70: 171-174
10. Federschneider JM, Yuan L, Brodsky J, Breslin G, Betensky RA, Crum CP (2004) The borderline or weakly positive Hybrid Capture II HPV test: a statistical and comparative (PCR) analysis. Am J Obstet Gynecol 191: 757-761
11. Franklin RD, Kutteh WH (1999) Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. J Reprod Immunol 42: 83-106
12. Gay JD, Donaldson LD, Goellner JR (1985) False-negative results in cervical cytologic studies. Acta Cytol 29: 1043-1046
13. Gorodeski GI (1998) Estrogen increases the permeability of the cultured human cervical epithelium by modulating cell deformability. Am J Physiol Cell Physiol 275: 888-899
14. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ (2000) Improved amplification of genital human papillomaviruses. J Clin Microbiol 38: 357-361
15. Harper DM, Longacre MR, Noll WM, Belloni DR, Cole BF (2003) Factors affecting the detection rate of human papillomavirus. Ann Fam Med 1: 221-227
16. Henry JA, Wadehra V (1996) Influence of smear quality on the rate of detecting significant cervical cytologic abnormalities. Acta Cytol 40: 529-535
17. Josefsson AM, Magnuson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB (2000) Viral load of human papilloma virus 16 as a determinant for the development of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2189-2193
18. Lorincz A (1996) Hybrid Capture™ method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep 7: 1-5
19. Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M (2002) Viral load of human papillomavirus and risk of CIN3 or cervical cancer (research letter). Lancet 360: 228-229
20. McGarahan A, Smith-McCune K (2005) Follow-up of unsatisfactory Papanicolaou results (research letters). JAMA 283: 1290-1291
21. Mintzer M, Curtis P, Resnick JC, Morrell D (1999) The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities. Cancer Cytopathol 87: 113-117
22. Mitchell H, Medley G, Giles G (1990) Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s. Br Med J 300: 1622-1626
23. Nardelli-Haefliger D, Wirthner D, Schiller JT, Lowy DR, Hildesheim A, Ponci F, De Grandi P (2003) Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst 95: 1128-1137
24. Nygard JF, Sauer T, Nygard M, Skare GB, Thoresen SO (2004) CIN 2/3 and cervical cancer in an organized screening programme after an unsatisfactory or a normal Pap smear: a seven-year study of the Norwegian population-based screening programme. J Med Screen 11: 70-76
25. Pairwuti S (1991) False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix. Acta Cytol 35: 40-46
26. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM (2001) Determinants of genital human papillomavirus detection in a US population. J Infect Dis 183: 1554-1564
27. Ransdell JS, Davey DD, Zaleski S (1997) Clinicopathologic correlation of the unsatisfactory Papanicolaou smear. Cancer Cytopathol 81: 139-143
28. Renshaw AA, Young NA, Birdsong GG, Styer PE, Davey DD, Mody DR, Colgan TJ (2004) Comparison of performance of conventional and ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program. Arch Pathol Lab Med 128: 17-22
29. Schiffman M, Adrianza ME (2000) ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 44: 726-742
30. Schneider A, Kirchhoff T, Meinhardt G, Gissman L (1992) Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears. Obstet Gynecol 79: 683-688
31. Sherman ME, Schiffman M, Cox JT, Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group (2002) Effects of age and human papillomaviral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 94: 102-107
32. Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M (2003) Determinants of human papillomavirus load among women with histologic cervical intraepithelial neoplasia 3: Dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarker Prev 12: 1034-1044
33. Solomon D (1991) The Bethesda System for reporting cervical/vaginal cytologic diagnosis: an overview. Int J Gynecol Pathol 10: 323-325
34. The ASCUS-LSIL Triage Study (ALTS) Group (2003) Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 188: 1383-1392
35. Van Ham MAPC, Melchers WJG, Hanselaar AGJM, Bekkers RLM, Boonstra H, Massuger LFAG (2002) Fluctuations in prevalence of cervical human papillomavirus in women frequently sampled during a single menstrual cycle. Br J Cancer 87: 373-376
36. Vooijs CP, van der Graaf Y, Elias AG (1987) Cellular composition of cervical smears in relation to the day of the menstrual cycle and the methods of contraception. Acta Cytol 31: 417-426
37. Wang Q, Li X, Wang L, Zeng R, Gorodeski G (2004) Antiapoptotic effects of estrogen in normal and cancer human cervical epithelial cells. Endocrinology 145: 556-579
38. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM (1996) Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 88: 261-268
39. Wilbur DC, Dubeshter B, Angel C, Akison KM (1996) Use of thin-layer preparations for gynecologic smears with emphasis on the cytomorphology of high-grade intraepithelial lesions and carcinoma. Diagn Cytopathol 14: 201-211